Low dose aspirin was found to improve survival in patients undergoing treatment for some head/neck and lung cancers, reported presentations at the American Society for Therapeutic Radiation Oncology (ASTRO) Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center.
The retrospective analyses are among the first to suggest a benefit in overall survival for patients with either head and neck squamous cell carcinoma (HNSCC) or early-stage non-small cell lung cancer (NSCLC) ...
Low dose aspirin was found to improve survival in patients undergoing treatment for some head/neck and lung cancers, reported presentations at the American Society for Therapeutic Radiation Oncology (ASTRO) Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center.
The retrospective analyses are among the first to suggest a benefit in overall survival for patients with either head and neck squamous cell carcinoma (HNSCC) or early-stage non-small cell lung cancer (NSCLC) ...